12 Best Hot Stocks to Invest In
On September 24, Ryan Detrick, Carson Group chief market strategist, joined CNBC's 'Power Lunch' to discuss why he still expects a strong end-of-year rally.
Olema Pharmaceuticals Inc. (OLMA)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 5,295,893 | $22,560,504 | 0.81% | |
| 2. | Woodline Partners Michael Rockefeller And Karl Kroeker | 3,505,893 | $14,935,104 | +138% | 0.08% |
| 3. | Deep Track Capital David Kroin | 3,442,833 | $14,666,469 | 0.47% | |
| 4. | Logos Capital Arsani William | 3,208,875 | $13,669,808 | 1.51% | |
| 5. | BioImpact Capital Mpm Capital | 2,378,762 | $10,133,526 | -19% | 1.76% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.76 | 300,000 | $1,727,370.00 | 7,800,000 | 2025-01-08 | Filing | |
| $6.75 | 700,761 | $4,730,136.75 | 700,761 | 2024-12-13 | Filing | |
| $6.75 | 700,761 | $4,730,136.75 | 1,408,875 | 2024-12-17 | Filing | |
| $13.09 | 50,000 | $654,250.00 | 1,800,000 | 2023-12-05 | Filing | |
| $14.95 | 50,000 | $747,480.00 | 1,750,000 | 2023-12-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.32 | 3,086 | $25,675.52 | 117,028 | 2025-09-18 | Filing | |
| $8.08 | 1,914 | $15,465.12 | 120,114 | 2025-09-16 | Filing | |
| $8.33 | 10,000 | $83,300.00 | 744,140 | 2025-09-18 | Filing | |
| $8.04 | 10,000 | $80,400.00 | 754,140 | 2025-09-16 | Filing | |
| $6.75 | 700,761 | $4,730,136.75 | 0 | 2024-12-13 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,082 | $108,493 | 0% | |
| 2. | 231 | $2,261 | 0% | |
| 3. | 30 | $294 | 0% |
News See All
Goldman Sachs Raises Stake in Olema Pharmaceuticals, Inc. (OLMA)
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) is among the best fast money stocks to buy now. During the first quarter, Goldman Sachs Group Inc. expanded its holdings in Olema Pharmaceuticals, Inc.
11 Best Fast Money Stocks to Buy Now
In this fast-paced world, most people have become impatient. Everyone is drawn to whatever delivers quick results, whether it be fast fame or fast money.
Clinical Trial Progress and Analyst Endorsement Spark Short-Term Rebound for Olema Pharmaceuticals
Headquartered in California, Olema Pharmaceuticals, Inc.
11 Best Short-Term Stocks to Invest in
The latter half of the 2025 market is caught between conflicting signals.
H.C. Wainwright Backs Olema Pharmaceuticals (OLMA) as Phase 3 Trials Advance
On May 28, Olema Pharmaceuticals, Inc.
15 Small-Cap Stocks with High Potential
In this article, we will take a look at the 15 small-cap stocks with high potential.
12 Best Performing NASDAQ Stocks in 2023
In this piece, we will take a look at the 12 best performing NASDAQ stocks in 2023.
5 Best Performing Biotech Stocks in 2023
In this piece, we will take a look at the five best performing biotechnology stocks in 2023.
8 Stocks in Eashwar Krishnan's Tybourne Capital Management Portfolio
In this article, we will take a look at some of the stocks in Eashwar Krishnan’s Tybourne Capital Management portfolio.
Hedge Fund Resource Center Billionaire Hedge Funds
